$BRVE
Price history, market instrument context, member research, and related headlines in one place.
BRVE key statistics
NasdaqGMUSD
52-week range
$17.8612%$32.00
Latest session $19.18–$20.13Braveheart Bio, Inc. (BRVE) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $19.55, up $0.21 (1.09%) from the previous close of $19.34. It has traded between $19.18 and $20.13 in the latest session. Over the past year it has ranged from $17.86 to $32.00, leaving it in the lower quarter of its 52-week range (12%). Reported volume for the session was 205.7K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Braveheart Bio closes $439.9 million IPO on Nasdaq — See source for full details.
Braveheart Bio targets $1.2 billion valuation in US IPO — See source for full details.
Loading $BRVE research…